Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicholas J Mangieri"'
Autor:
Zev M, Nakamura, Sanah N, Vohra, Christopher E, Jensen, Kirsten A, Nyrop, Allison M, Deal, Hillary M, Heiling, Nicholas J, Mangieri, Shakira J, Grant, Eben I, Lichtman, Samuel M, Rubinstein, William A, Wood, Hyman B, Muss, Sascha A, Tuchman
Publikováno v:
Journal of Geriatric Oncology. 13:987-996
Older adults with plasma cell disorders (PCDs) experience cognitive dysfunction that may be attributable to the disease and associated therapies. Yet, this has seldom been reported in the literature. Our objectives were to describe cognitive function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fa179c9099d18738246a634cdf550fe
https://doi.org/10.1016/j.jgo.2022.04.010
https://doi.org/10.1016/j.jgo.2022.04.010
Autor:
Samuel M. Rubinstein, Eben I. Lichtman, Shakira Jeanene Grant, Christopher E. Jensen, Hyman B. Muss, Nicholas J. Mangieri, Sanah N. Vohra, Allison M. Deal, Lee Jamison, William A. Wood, Sascha A. Tuchman, Kirsten A. Nyrop
Publikováno v:
J Geriatr Oncol
OBJECTIVES: Findings from a brief geriatric assessment (GA) in a cohort of adults with multiple myeloma (MM) are presented, with particular attention to the utility of the GA in identifying important deficits in adults judged to have a normal Karnofs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca926be187e904683da7ed5a03a6243
https://doi.org/10.1016/j.jgo.2021.08.004
https://doi.org/10.1016/j.jgo.2021.08.004
Autor:
Abdel Rahem S. Yusuf, Hillary M. Heiling, Allison M. Deal, Christopher E. Jensen, Nicholas J. Mangieri, Kirsten A. Nyrop, Eben I. Lichtman, Samuel M. Rubinstein, Shakira J. Grant, William A. Wood, Sascha A. Tuchman, Zev M. Nakamura
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(12)
Cancer-related cognitive impairment (CRCI) has been largely unstudied in patients with multiple myeloma (MM). This study describes patient-reported cognition over time and patient factors associated with adverse cognitive outcomes in MM.Participants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be8fdc4e49748aaed73b18961d2ec804
https://pubmed.ncbi.nlm.nih.gov/36085276
https://pubmed.ncbi.nlm.nih.gov/36085276
Autor:
Christopher E Jensen, Sanah N Vohra, Kirsten A Nyrop, Allison M Deal, Matthew R LeBlanc, Shakira J Grant, Hyman B Muss, Eben I Lichtman, Samuel M Rubinstein, William A Wood, Nicholas J Mangieri, Lee Jamison, Sascha A Tuchman
Publikováno v:
The oncologist. 27(8)
BackgroundThe plasma cell disorders (PCDs), multiple myeloma (MM), and light-chain amyloidosis (AL) are disproportionately diseases of older adults, whose care may be complicated by frailty associated with advancing age. We sought to evaluate the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aa2091aae691e3912897d79379bf9ce
https://pubmed.ncbi.nlm.nih.gov/35511734
https://pubmed.ncbi.nlm.nih.gov/35511734